Skip to the main content

Original scientific paper

https://doi.org/10.15644/asc52/2/4

Comparison of Amitriptyline with Stabilization Splint and Placebo in Chronic TMD Patients: a Pilot Study

Iva Ž Alajbeg ; Department of Prosthodontics, School of Dental Medicine, University of Zagreb, Zagreb, Croatia
Ratka Borić Brakus ; PhD student, School of Dental Medicine, University of Zagreb, Zagreb, Croatia
Ivan Brakus ; Study of Dental Medicine, School of Medicine Split, University of Split, Split, Croatia


Full text: croatian pdf 278 Kb

page 114-122

downloads: 412

cite

Full text: english pdf 278 Kb

page 114-122

downloads: 1.031

cite


Abstract

Objective of work: The authors conducted a clinical study to evaluate the effectiveness of amitriptyline in treatment of chronic TMD patients and to compare treatment results with stabilization splint. Materials and Methods: Twenty-one patients with chronic TMD were included and randomly distributed into 3 groups: patients in Group A received amitriptyline, patients in Group B received placebo, and those in Group C were treated with stabilization splint. Treatment outcomes (pain assessed by a visual analogue scale (VAS), maximal comfortable mouth opening (MCO) and oral health related quality of life (OHIP-14)) were taken at baseline (before treatment), and at 1st, 6th and 12th week of
treatment. Results: No statistically significant differences between the groups at baseline were found (p>0.05). VAS scores improved significantly in Group A (F=11.326, p=0.002, effect size =0.791) and
in group C (F=7.343, p=0.005, effect size=0.647). Mean OHIP-14 scores decreased significantly only in Group A (F=4.417, p=0.036, effect size =0.596). In Group B, VAS and OHIP-14 scores did not change significantly over time. Subjects in Group C had a significant change in MCO relative to Group A and Group B. Conclusion: From this pilot study it can be concluded that the use of low doses of amitriptyline
for a period of 12 weeks is effective for pain management and quality of life improvement in chronic TMD patients. Stabilization splint demonstrated superiority in the management of limited mouth opening during the same period.

Keywords

Amitriptyline; Temporomandibular Joint Disorders; Occlusal Splints; Chronic Pain

Hrčak ID:

201262

URI

https://hrcak.srce.hr/201262

Publication date:

12.6.2018.

Article data in other languages: croatian

Visits: 2.684 *